Predictive costs in medical care for Koreans with metabolic syndrome from 2009 to 2013 based on the National Health Insurance claims dataset

Abstract

Background/Aims Although metabolic syndrome has been associated with increasing medical costs worldwide, there have been no studies using a nationwide and longitudinal South Korean dataset. We investigated trends in subsidized medical costs among Korean adults with metabolic syndrome. Methods This study was based on the National Sample Cohort database of South Korea. We used data of national health checkups in 2009 as well as data of subsidized prescription drugs and the Korean Classification of Disease diagnosis codes from claims in 2007 to 2008 to identify underlying diseases. We calculated the direct medical costs, which were subsidized by the Korean National Health Insurance, among 204,768 individuals older than 20 years from 2009 to 2013. Results The proportion of subjects with metabolic syndrome was 27.2%. Direct medical costs for 5 years differed by a magnitude of 2.16 between subjects with and without metabolic syndrome. The costs increased by approximately 41.8% in the metabolic syndrome group in 5 years. Direct medical costs increased with every additional risk factor, even if a subject had less than three risk factors of metabolic syndrome. Metabolic syndrome per se and all of its components, except low serum high-density lipoprotein cholesterol level, resulted in a significant increase in medical costs. Conclusions The medical costs of subjects with metabolic syndrome were higher than that of those without metabolic syndrome and it increased with the number of risk factors. Further research using cumulative data of more than 10 years, including unsubsidized and indirect costs, is needed in the future.

Cost-Effectiveness Analysis of Hypertension Screening in the Korea National Health Screening Program

“…The screening targets should be established based on each nation's HTN prevalence, healthcare system, socioeconomic status, and cost-effectiveness analysis (CEA). 6) In Korea, the national health-screening program controlled by the government at a national level was launched in 1980. Korea is investing more than 700 billion KRW in the national health examination, and many large private medical institutions are expanding their screening competitively in national screening program.…”

Association between office visit intervals and long‐term cardiovascular risk in hypertensive patients

“…This study offers real‐world evidence by merging deep phenotypic data from hospital data and long‐term follow‐up by utilizing big public health data. Korea has a single government‐maintained NHIS that provides free biennial health examination data, medical services, and pharmacy claims data 11,25,26 . However, there is a lack of detailed clinical data in the health claims database, especially in terms of blood pressure values, which may include critical chronic disease data that require repetitive measurement of clinical factors.…”

“…11,25,26 However, there is a lack of detailed clinical data in the health claims database, especially in terms of blood pressure values, which may include critical chronic disease data that require repetitive measurement of clinical factors. In contrast,…”

The Korean Hypertension Cohort study: design and baseline characteristics

“…Real world evidence, especially that utilizing big public health data, has potential benefits, such as allowing for long-term follow-up of a large number of patients [ 19 , 20 ]. Korea has a single, government maintained NHIS [ 21 , 22 ]. The universal NHIS provides free biennial health examinations to eligible NHIS members aged ≥ 40 years.…”